Thomas A. Morinelli

874 total citations
18 papers, 729 citations indexed

About

Thomas A. Morinelli is a scholar working on Pharmacology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Thomas A. Morinelli has authored 18 papers receiving a total of 729 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 4 papers in Molecular Biology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Thomas A. Morinelli's work include Inflammatory mediators and NSAID effects (5 papers), Eicosanoids and Hypertension Pharmacology (4 papers) and Receptor Mechanisms and Signaling (4 papers). Thomas A. Morinelli is often cited by papers focused on Inflammatory mediators and NSAID effects (5 papers), Eicosanoids and Hypertension Pharmacology (4 papers) and Receptor Mechanisms and Signaling (4 papers). Thomas A. Morinelli collaborates with scholars based in United States, India and Lebanon. Thomas A. Morinelli's co-authors include Perry V. Halushka, Stefan Niewiarowski, Dale E. Mais, Philip R. Mayeux, Gwendolyn J. Stewart, Andrzej Budzyński, Robert W. Colman, L H Edmunds, Diáne Hershock and J. Musial and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of Medicinal Chemistry.

In The Last Decade

Thomas A. Morinelli

18 papers receiving 693 citations

Peers

Thomas A. Morinelli
David C. B. Mills United States
M A Orchard United Kingdom
Katharina Lötzer Germany
Miriam H. Fukami Norway
Thomas M. Coffman United States
J.W.N. Akkerman Netherlands
Jennifer Yeung United States
Meei Jyh Jiang Taiwan
O. Tangen Sweden
Jon Vincelette United States
David C. B. Mills United States
Thomas A. Morinelli
Citations per year, relative to Thomas A. Morinelli Thomas A. Morinelli (= 1×) peers David C. B. Mills

Countries citing papers authored by Thomas A. Morinelli

Since Specialization
Citations

This map shows the geographic impact of Thomas A. Morinelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas A. Morinelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas A. Morinelli more than expected).

Fields of papers citing papers by Thomas A. Morinelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas A. Morinelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas A. Morinelli. The network helps show where Thomas A. Morinelli may publish in the future.

Co-authorship network of co-authors of Thomas A. Morinelli

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas A. Morinelli. A scholar is included among the top collaborators of Thomas A. Morinelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas A. Morinelli. Thomas A. Morinelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Ullian, Michael E., Louis M. Luttrell, Mi‐Hye Lee, & Thomas A. Morinelli. (2014). Stimulation of Cyclooxygenase 2 Expression in Rat Peritoneal Mesothelial Cells. Nephron Experimental Nephrology. 128(3-4). 89–97. 2 indexed citations
2.
Wilson, Parker C., Mi‐Hye Lee, Kathryn M. Appleton, et al.. (2013). The Arrestin-selective Angiotensin AT1 Receptor Agonist [Sar1,Ile4,Ile8]-AngII Negatively Regulates Bradykinin B2 Receptor Signaling via AT1-B2 Receptor Heterodimers. Journal of Biological Chemistry. 288(26). 18872–18884. 43 indexed citations
3.
Ullian, Michael E., et al.. (2005). N-Acetylcysteine Decreases Angiotensin II Receptor Binding in Vascular Smooth Muscle Cells. Journal of the American Society of Nephrology. 16(8). 2346–2353. 40 indexed citations
4.
Cabrera, David, Michael G. Janech, Thomas A. Morinelli, & D. H. Miller. (2003). A thromboxane A2 system in the Atlantic stingray, Dasyatis sabina. General and Comparative Endocrinology. 130(2). 157–164. 2 indexed citations
5.
Tempel, G, et al.. (2001). CHANGES IN VASCULAR RESPONSIVENESS TO A THROMBOXANE MIMETIC IN ENDOTOXIN TOLERANCE. Shock. 16(5). 389–392. 4 indexed citations
6.
Halushka, Perry V., Katsuhiro Matsuda, Akira Masuda, et al.. (1995). Testosterone Regulation of Platelet and Vascular Thromboxane A2 Receptors. Birkhäuser Basel eBooks. 45. 19–26. 4 indexed citations
7.
8.
Bowling, Nancy, et al.. (1991). 1 – (CARBOXYBENZY1) IMIDAZOLE – 5 – ACRYLIC ACIDS: POTENT AND SELECTIVE ANGIOTENSIN II RECEPTOR ANTAGONISTS. 34. 1514–1517. 15 indexed citations
9.
Mais, Dale E., Nancy Bowling, Timothy A. True, et al.. (1991). Novel synthesis and biochemical properties of an [125I]-labeled photoaffinity probe for thromboxane A2/prostaglandin H2 receptors. Journal of Medicinal Chemistry. 34(4). 1511–1514. 22 indexed citations
10.
Morinelli, Thomas A., et al.. (1990). I-BOP, the most potent radiolabelled agonist for the TXA2/PGH2 receptor.. PubMed. 20. 102–9. 6 indexed citations
11.
12.
Halushka, Perry V., Dale E. Mais, Philip R. Mayeux, & Thomas A. Morinelli. (1989). Thromboxane, Prostaglandin and Leukotriene Receptors. The Annual Review of Pharmacology and Toxicology. 29(1). 213–239. 221 indexed citations
13.
Fried, Josef, Varghese John, Counde O-Yang, et al.. (1989). Synthesis of 10,10-difluorothromboxane A2, a potent and chemically stable thromboxane agonist. Journal of the American Chemical Society. 111(12). 4510–4511. 19 indexed citations
14.
Morinelli, Thomas A., Stefan Niewiarowski, James L. Daniel, & J. Bryan Smith. (1987). Receptor-mediated effects of a PGH2 analogue (U 46619) on human platelets. American Journal of Physiology-Heart and Circulatory Physiology. 253(5). H1035–H1043. 33 indexed citations
15.
Switalska, Hanna I., Stefan Niewiarowski, George P. Tuszynski, et al.. (1985). Radioimmunoassay of human platelet thrombospondin: different patterns of thrombospondin and beta-thromboglobulin antigen secretion and clearance from the circulation.. PubMed. 106(6). 690–700. 33 indexed citations
16.
Musial, J., Stefan Niewiarowski, Diáne Hershock, et al.. (1985). Loss of fibrinogen receptors from the platelet surface during simulated extracorporeal circulation.. PubMed. 105(4). 514–22. 80 indexed citations
17.
18.
Niewiarowski, Stefan, et al.. (1981). Exposure of fibrinogen receptor on human platelets by proteolytic enzymes.. Journal of Biological Chemistry. 256(2). 917–925. 137 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David C. B. Mills Breakdown of academic impact, for papers by M A Orchard Breakdown of academic impact, for papers by Katharina Lötzer Breakdown of academic impact, for papers by Miriam H. Fukami Breakdown of academic impact, for papers by Thomas M. Coffman Breakdown of academic impact, for papers by J.W.N. Akkerman Breakdown of academic impact, for papers by Jennifer Yeung Breakdown of academic impact, for papers by Meei Jyh Jiang Breakdown of academic impact, for papers by O. Tangen Breakdown of academic impact, for papers by Jon Vincelette
Rankless by CCL
2026